← Open Payments lookup

GHADA AL-ASADI: Open Payments

NPI 1598875239 · GLENDORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,506 in 65 payments from 13 companies in 2025. Trend: 2023 $2,290 · 2024 $1,182 · 2025 $1,506

Food & beverage: $1,507
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.15$438
Otsuka America Pharmaceutical, Inc.10$222
ABBVIE INC.12$172
Teva Pharmaceuticals USA, Inc.6$121
Alkermes, Inc.5$110
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$101
Alpha Cognition USA, Inc.2$93
E.R. Squibb & Sons, L.L.C.3$78
Takeda Pharmaceuticals U.S.A., Inc.3$57
Janssen Pharmaceuticals, Inc2$42

Products named: HETLIOZ, REXULTI, VRAYLAR, ARISTADA, CAPLYTA, UZEDY, Zunveyl, COBENFY.

Industry payments across CA — which companies pay providers there.